Ho Yu Ng
Appearances
- DateMay 20, 2024BACKGROUND AND AIM: We aimed to compare efficacy of vonoprazan-based therapies and bismuth-based quadruple therapy as first-line treatment for _Helicobacter pylori_ (_H. pylori_) infection in Southern China, where high primary resistance rates of clarithromycin and levofloxacin (>30%) exist…
Presenter
Speakers
University of Hong Kong Li Ka Shing Faculty of Medicine - DateMay 18, 2024BACKGROUND: While sodium-glucose cotransporter 2 inhibitors improves cardiovascular and renal outcomes irrespective of diabetes mellitus (DM) status, their effects in metabolic-dysfunction associated steatotic liver disease (MASLD) patients without diabetes mellitus (DM) are unknown…
Presenter
Speakers
University of Hong Kong Li Ka Shing Faculty of Medicine